tirzepatide nejm for the Treatment of Obstructive Sleep Apnea and Obesity A 3-year study of tirzepatide
Description
Hello again, nausea and feeling extra full after meals
The weight loss induced by liraglutide at 3 mg is typically in the range of 510% after 52 wk of treatment of non-diabetic obese patients [895]
In there was a study where serious, like what they call serious chemo toxicity showed up in 50% of the low muscle patients, but only 20% of the other patients
As long as the trend line moves in the right direction, the protocol is working
10.1038/oby.2011.330 [EL 1
As patients switch from taking LT4 medication to thyroid extract they tend to experience a better quality of life and more weight loss
